Malekiantaghi Armen, Aghajani Mahbobeh, Shabani-Mirzaee Hosein, Vigeh Mohsen, Eftekhari Kambiz
Department of Pediatric Gastroenterology, Bahrami Children's Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Department of Pediatric, Bahrami Children's Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
BMC Nutr. 2024 Jul 19;10(1):101. doi: 10.1186/s40795-024-00901-6.
Cow's milk protein allergy (CMPA) is one of the most common food allergies in the first year of life. Special formulas for infants with CMPA include extensively hydrolyzed (EHFs) and amino acid-based (AAFs) formulas. The aim of this study was to evaluate the growth of infants fed with these special formulas.
This was a prospective chart review study that evaluated the growth criteria of infants with CMPA fed with EHFs or AAFs until one year of age. These infants were referred to the gastroenterology clinic of Bahrami Children's Hospital from April 2021 to April 2022. These infants were divided into two groups, the group fed with EHFs and AAFs. Then growth criteria were evaluated in both groups.
Fifty-eight children were enrolled in the study, of which 51.7% were girls. Forty were consuming the EHFs formulas. The median time of both diagnosis and treatment was 60 days. The most common clinical manifestations were gastroesophageal reflux, dysentery, eczema, vomiting, and cough, respectively. The diagnosis of the disease in the AAFs group was significantly earlier than in the other group. The growth of children in both groups was completely proportional to their age and growth criteria at birth. Comparing the groups, all growth parameters were higher in the EHFs group.
This study showed that the growth criteria (weight, length, and head circumference) were suitable for each group and were in accordance with the WHO growth charts compared to the birth criteria. But in the group fed with EHFs, compared to AAFs, the growth rate was higher.
牛奶蛋白过敏(CMPA)是一岁以内最常见的食物过敏之一。用于患有CMPA的婴儿的特殊配方奶粉包括深度水解配方奶粉(EHFs)和氨基酸配方奶粉(AAFs)。本研究的目的是评估喂养这些特殊配方奶粉的婴儿的生长情况。
这是一项前瞻性图表回顾研究,评估了喂养EHFs或AAFs直至一岁的患有CMPA的婴儿的生长标准。这些婴儿在2021年4月至2022年4月期间被转诊至巴赫拉米儿童医院的胃肠病诊所。这些婴儿被分为两组,即喂养EHFs的组和喂养AAFs的组。然后对两组的生长标准进行评估。
58名儿童参与了该研究,其中51.7%为女孩。40名儿童食用EHFs配方奶粉。诊断和治疗的中位时间均为60天。最常见的临床表现分别为胃食管反流、痢疾、湿疹、呕吐和咳嗽。AAFs组疾病的诊断明显早于另一组。两组儿童的生长与他们出生时的年龄和生长标准完全成比例。比较两组,EHFs组的所有生长参数均更高。
本研究表明,与出生标准相比,生长标准(体重、身长和头围)适用于每组,并且符合世界卫生组织生长图表。但与AAFs组相比,喂养EHFs的组生长速度更高。